April 27, 2010 / 6:19 AM / 9 years ago

BRIEF-Novo Nordisk ups 2010 sales, profit guidance

COPENHAGEN, April 27 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO) said on Tuesday:

* Company sees 2010 sales growth of 7-10 pct in local currencies (vs previous forecast of 6-10 pct)

* Sees 2010 reported sales growth around 3 percentage points above growth in local currencies (vs previous guidance of a similar growth level)

* Sees 2010 operating profit growth of more than 10 pct in local currencies (vs previous forecast of around 10 pct)

* Sees 2010 reported operating profit growth around 6 percentage points above growth in local currencies (vs previous forecast of a similar growth level)

* Victoza rollout progressing well in United States and Europe

* Victoza now commercially available in 15 countries

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below